Alkhanfar Dheyaa, Shahin Yousef, Alandejani Faisal, Dwivedi Krit, Alabed Samer, Johns Chris, Lawrie Allan, Thompson A A Roger, Rothman Alexander M K, Tschirren Juerg, Uthoff Johanna M, Hoffman Eric, Condliffe Robin, Wild Jim M, Kiely David G, Swift Andrew J
Dept of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, UK.
INSIGNEO, Institute for In Silico Medicine, University of Sheffield, Sheffield, UK.
ERJ Open Res. 2022 May 16;8(2). doi: 10.1183/23120541.00503-2021. eCollection 2022 Apr.
Pulmonary hypertension (PH) in patients with chronic lung disease (CLD) predicts reduced functional status, clinical worsening and increased mortality, with patients with severe PH-CLD (≥35 mmHg) having a significantly worse prognosis than mild to moderate PH-CLD (21-34 mmHg). The aim of this cross-sectional study was to assess the association between computed tomography (CT)-derived quantitative pulmonary vessel volume, PH severity and disease aetiology in CLD.
Treatment-naïve patients with CLD who underwent CT pulmonary angiography, lung function testing and right heart catheterisation were identified from the ASPIRE registry between October 2012 and July 2018. Quantitative assessments of total pulmonary vessel and small pulmonary vessel volume were performed.
90 patients had PH-CLD including 44 associated with COPD/emphysema and 46 with interstitial lung disease (ILD). Patients with severe PH-CLD (n=40) had lower small pulmonary vessel volume compared to patients with mild to moderate PH-CLD (n=50). Patients with PH-ILD had significantly reduced small pulmonary blood vessel volume, compared to PH-COPD/emphysema. Higher mortality was identified in patients with lower small pulmonary vessel volume.
Patients with severe PH-CLD, regardless of aetiology, have lower small pulmonary vessel volume compared to patients with mild-moderate PH-CLD, and this is associated with a higher mortality. Whether pulmonary vessel changes quantified by CT are a marker of remodelling of the distal pulmonary vasculature requires further study.
慢性肺病(CLD)患者的肺动脉高压(PH)预示着功能状态下降、临床病情恶化及死亡率增加,重度PH-CLD(≥35 mmHg)患者的预后明显差于轻度至中度PH-CLD(21-34 mmHg)患者。这项横断面研究的目的是评估计算机断层扫描(CT)得出的定量肺血管容积、PH严重程度与CLD疾病病因之间的关联。
从2012年10月至2018年7月的ASPIRE注册研究中,确定未接受过治疗且接受过CT肺血管造影、肺功能测试和右心导管检查的CLD患者。对总肺血管和小肺血管容积进行定量评估。
90例患者患有PH-CLD,其中44例与慢性阻塞性肺疾病/肺气肿相关,46例与间质性肺疾病(ILD)相关。与轻度至中度PH-CLD患者(n=50)相比,重度PH-CLD患者(n=40)的小肺血管容积更低。与PH-慢性阻塞性肺疾病/肺气肿患者相比,PH-ILD患者的小肺血管容积明显减少。小肺血管容积较低的患者死亡率更高。
与轻度至中度PH-CLD患者相比,重度PH-CLD患者无论病因如何,其小肺血管容积均较低,且这与更高的死亡率相关。CT定量的肺血管变化是否是远端肺血管重塑的标志物,需要进一步研究。